322 related articles for article (PubMed ID: 22996451)
21. Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion.
Walter E; Vielmuth F; Wanuske MT; Seifert M; Pollmann R; Eming R; Waschke J
Front Immunol; 2019; 10():1128. PubMed ID: 31178865
[TBL] [Abstract][Full Text] [Related]
22. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
Cirillo N; Femiano F; Gombos F; Lanza A
Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
[TBL] [Abstract][Full Text] [Related]
23. Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease.
Cho A; Caldara AL; Ran NA; Menne Z; Kauffman RC; Affer M; Llovet A; Norwood C; Scanlan A; Mantus G; Bradley B; Zimmer S; Schmidt T; Hertl M; Payne AS; Feldman R; Kowalczyk AP; Wrammert J
Cell Rep; 2019 Jul; 28(4):909-922.e6. PubMed ID: 31340153
[TBL] [Abstract][Full Text] [Related]
24. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
Chernyavsky A; Amber KT; Agnoletti AF; Wang C; Grando SA
J Biol Chem; 2019 Mar; 294(12):4520-4528. PubMed ID: 30692201
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
[TBL] [Abstract][Full Text] [Related]
26. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.
Saito M; Stahley SN; Caughman CY; Mao X; Tucker DK; Payne AS; Amagai M; Kowalczyk AP
PLoS One; 2012; 7(12):e50696. PubMed ID: 23226536
[TBL] [Abstract][Full Text] [Related]
27. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
28. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
Luyet C; Schulze K; Sayar BS; Howald D; Müller EJ; Galichet A
PLoS One; 2015; 10(3):e0119809. PubMed ID: 25748204
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
[TBL] [Abstract][Full Text] [Related]
30. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
31. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies.
Hacker MK; Janson M; Fairley JA; Lin MS
Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995
[TBL] [Abstract][Full Text] [Related]
32. Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules.
Ohyama B; Nishifuji K; Chan PT; Kawaguchi A; Yamashita T; Ishii N; Hamada T; Dainichi T; Koga H; Tsuruta D; Amagai M; Hashimoto T
J Invest Dermatol; 2012 Apr; 132(4):1158-68. PubMed ID: 22277941
[TBL] [Abstract][Full Text] [Related]
33. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
Szabados H; Bősze S; Silló P; Kárpáti S; Hudecz F; Uray K
J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
[TBL] [Abstract][Full Text] [Related]
34. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies.
Calkins CC; Setzer SV; Jennings JM; Summers S; Tsunoda K; Amagai M; Kowalczyk AP
J Biol Chem; 2006 Mar; 281(11):7623-34. PubMed ID: 16377623
[TBL] [Abstract][Full Text] [Related]
35. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris.
Müller R; Svoboda V; Wenzel E; Gebert S; Hunzelmann N; Müller HH; Hertl M
Exp Dermatol; 2006 Aug; 15(8):606-14. PubMed ID: 16842599
[TBL] [Abstract][Full Text] [Related]
36. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
37. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
[TBL] [Abstract][Full Text] [Related]
38. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
39. Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus Vulgaris.
Didona D; Scarsella L; Hudemann C; Volkmann K; Zimmer CL; Beckert B; Tikkanen R; Korff V; Kühn K; Wienzek-Lischka S; Bein G; Di Zenzo G; Böhme J; Cunha T; Solimani F; Pieper J; Juratli HA; Göbel M; Schmidt T; Borradori L; Yazdi AS; Sitaru C; Garn H; Eming R; Fleischer S; Hertl M
J Invest Dermatol; 2024 Feb; 144(2):263-272.e8. PubMed ID: 37717934
[TBL] [Abstract][Full Text] [Related]
40. Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides.
Dworschak J; Recke A; Freitag M; Ludwig RJ; Langenhan J; Kreuzer OJ; Zillikens D; Schmidt E
J Dermatol Sci; 2012 Feb; 65(2):102-9. PubMed ID: 22261006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
